SCHEMBL6529995

SCHEMBL6529995

COC(=O)[C@@H](CC(C)C)Nc1nc(NCCOCCO)nc(Nc2cccc(F)c2)n1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
KCNH3 Q9ULD8 7/20 0.52
NPC1 O15118 1/20 0.42
CDK5 Q00535 1/20 0.42
CDK5R1 Q15078 1/20 0.42
NPR3 P17342 3/20 0.39
SCN9A Q15858 1/20 0.39
GBA1 P04062 1/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
GSK3A P49840 1/20 0.39
GSK3B P49841 1/20 0.39
EGFR P00533 1/20 0.38
CCNA2 P20248 1/20 0.38
CDK2 P24941 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6529989 1.00 MEN1 (0.52) MEN1KMT2AKCNH3NPC1CDK5
SCHEMBL6529452 0.86 CDC7 (0.44) KCNH3NPC1CDK5CDK5R1NPR3
SCHEMBL6529455 0.86 CDC7 (0.44) KCNH3NPC1CDK5CDK5R1NPR3
SCHEMBL6530463 0.83 NPR3 (0.55) KCNH3NPR3POLBCYP2C9CYP2C19
SCHEMBL6530469 0.83 NPR3 (0.55) KCNH3NPR3POLBCYP2C9CYP2C19
SCHEMBL6527960 0.83 NPR3 (0.43) MEN1KMT2AKCNH3NPC1CDK5
SCHEMBL6527972 0.83 NPR3 (0.43) MEN1KMT2AKCNH3NPC1CDK5
SCHEMBL6530423 0.83 ALDH1A1 (0.47) KCNH3GBA1CYP2C9CYP2C19
SCHEMBL6530426 0.83 ALDH1A1 (0.47) KCNH3GBA1CYP2C9CYP2C19
SCHEMBL6529544 0.81 NPR3 (0.41) MEN1KMT2AKCNH3CDK5NPR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO claimed
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO disclosed